# Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

> **NCT06278545** · PHASE2 · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 130 (estimated)

## Conditions studied

- Locally Advanced or Metastatic Small Bowel Adenocarcinoma

## Interventions

- **DRUG:** modified FOLFORINOX
- **DRUG:** Modified FOLFOX

## Key facts

- **NCT ID:** NCT06278545
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-16
- **Primary completion:** 2027-02
- **Final completion:** 2029-02
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06278545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06278545, "Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06278545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*